Division of Infectious Diseases

2025 Reflections From ID Chief – Dr. Warren

headshot of Dr. warren wearing a white coat with a blue collared shirt and blue tie. on sky blue background

As this year comes to a close, I want to reflect on my (almost) first year serving as Chief of the UNMC Infectious Diseases Division. 2025 started with unexpected changes – Dr. Debra Romberger stepping down from her role as Chair of Internal Medicine and Dr. Mark Rupp taking on the role as Interim Chair. I got to know Dr. Romberger during the interview process for the Division Chief position and in seeking her advice and counsel during my first few months at UNMC. In the all too brief time that I knew Dr. Romberger, I grew to understand how much of a strong, caring and dedicated leader she was. She will be missed. I want to recognize and thank Dr. Rupp for his leadership as Interim Chair of Internal Medicine. He agreed to take over the Department in a difficult time and has been a strong advocate and leader.  His dedication to both the ID Division and the Department of Internal Medicine has benefited all of us and advanced the mission of UNMC.

Besides myself, we welcomed Dr. Mohanad Al-Obaidi to the division as a new faculty member. We also welcomed 7 new staff members: Ja’Sia Ward, Caitlin Harrison, Katherine Kough, Toukatha Marupov, Daneja Menyweather, Lily Nyenga, and Caroline Song.

This year brought many great accomplishments and achievements for the ID Division. There are so many that I cannot do them all justice, but I wanted to call out a few: Dr. Nico Cortes-Penfield was promoted to Associate Professor and assumed the role of Section Leader for the Orthopedic ID Service. Dr. Elizabeth Schnaubelt was promoted to Colonel in the United States Ari Force. Dr. Jasmine Marcelin received the IDSA Foundation’s 2025 Diversity Champion Award, for her work in promoting equity and inclusion within infectious diseases. Dr. Kelly Cawcutt was selected by the Society of Critical Care Medicine as one of the recipients of the SCCM Presidential Citation.  Samantha Jones and Dr. Nada Fadul received Department of Internal Medicine Advocacy Awards. The Nebraska Antimicrobial Stewardship Program continues to be a leader in field with a global reach – its webpage was viewed 165,000 times last year with 42% of those sessions being by non-US users. Finally, we were a strong presence at numerous national and international scientific meetings – we gave talks and presented research at CROI, SHEA, and ESCMID, to name a few. We had a particularly strong showing at IDWeek, with 44 presentations by 30 members of our division, including several premedical students, medical students, pharmacy students, residents, and fellows.

Our division continues to excel in educating the next generation of clinicians. We graduated three ID fellows: Drs. Stephen Cooper, Tyler Rosengren, and Cristina Torres, and welcomed Drs. Charlie Oertli and Albert Wu into the fellowship program. We led courses for the medical students, residents, and fellows. We gave lectures on infectious diseases across multiple specialties, and for pharmacy, public health, and nursing students.  The ID Division has been consistently recognized for the excellent bedside teaching that we provide. Drs. Trevor VanSchooneveld, Jenn Davis, and Nicolas Cortes-Penfield received ID Fellow Top Teacher recognition; Drs. Jenn Davis, Sara Bares, and Jasmine Marcelin were also recognized as Top Teachers within the Department of Internal Medicine.

Members of the ID Division authored over 80 publications this year. We were authors of peer-reviewed original research, editorials, critical reviews, and national and international guidelines. We have research funded by NIH, CDC, DoD, HRSA, private foundations, along with numerous successful industry-sponsored clinical trials.

Core to our division’s mission is providing excellent clinical care. We have 5 active inpatient services, which see patients at multiple facilities within the region, and an active telemedicine group. This year, we were designated as a member of the Bronchiectasis and NTM Care Center Network, recognizing our expertise in treating patients living with mycobacterial infections. This multidisciplinary center is led by Dr. Rick Starlin. The Specialty Care Center was honored with the Visionary Award by HRSA for their innovative work in using telehealth to improve the care of people living with HIV in rural Nebraska.

Stepping into the role of Division Chief has been both humbling and rewarding. One of the best parts of this year has been getting to know the faculty and staff of the ID Division. Every day, I am reminded of the exceptional people who make this division what it is.  You are the reason that we take outstanding care of patients, advance the field of infectious diseases through new discoveries, and train the next generation of ID specialists. Thank you!

Best wishes to everyone in the ID Division and readers of the UNMC ID blog – I hope that you have wonderful holiday season with family and friends. I look forward to what we will accomplish in 2026!


 

Year-End Accolades! – We are so PROUD of our people!

Congratulations to members of our division for their achievements and recognitions in the second half of this year! These are just a few of the outstanding accomplishments of our division.

The HIV SCC EMET team were recognized as most active medical student clinic preceptorship in UNMC’s LCE (longitudinal clinic experience) program

Dr. Jasmine Marcelin was honored to receive the IDSA Foundation’s 2025 Diversity Champion Award, at IDWeek 2025

Nichole Regan, APRN and Dr. Emmanuel Nazaire Essam Nkodo were awarded second place for their project “Implementation of Comprehensive Behavioral Health and Substance Use Screening and Referral Services at a Midwest HIV Clinic”, by the Health Administration Research and Best Practices Symposium

Dr. Sias Scherger earned outstanding national recognition this week at the COLT Trial Investigator Meeting, where he was invited to present the UNMC experience

Dr. Kelly Cawcutt was selected by the Society of Critical Care Medicine as one of the recipients of the Presidential Citation Award

Dr. Shawna Sunagawa received the UNMC College of Pharmacy Teacher of the Year award

Dr. Salman Ashraf served as the Chair of the Infection Control Committee for the Society for Post-Acute and Long-Term Care Medicine and helped develop the society’s newly released guidance on COVID-19 vaccination for residents and staff in post-acute and long-term care settings.

Led by Dr. Jasmine Marcelin, the ID Division successfully competed for and was awarded the ID STEP grant through IDSA to develop the ID workforce. Faculty involved with developing the proposal included Drs. Mackenzie Keintz, Dan Brailita, Andrea Zimmer, Jenn Davis, Angela Hewlett, Andrea Green-Hines, David Warren, and Jonathan Ryder

Christine Tran, APRN received the Innovation Award at the UNMC APP Week Awards Ceremony

Dr. Kelly Cawcutt was selected as a distinguished speaker at the Remington Winter Course in Infectious Diseases in Copper Mountain, CO in February 2026

Dr. Dan Brailita was appointed Co-Chair of the Artificial Intelligence and Emerging Technologies COM Curriculum Integration Taskforce at UNMC

Samantha Jones, MSW received the UNMC Department of Internal Medicine Staff Excellence in Advocacy Award

Dr. Nada Fadul received the UNMC Department of Internal Medicine Debra J Romberger Faculty Excellence in Advocacy Award

Dr.  Jasmine Marcelin represented IDSA in Washington, DC at the Congressional Black Caucus Foundation Annual Legislative Conference

Dr. Josh Havens received the Scholar of the Year award from the UNMC College of Pharmacy

Drs. David Brett-Major, Angela Hewlett, and James Lawler contributed chapters to the new textbook Viral Outbreaks, Biosecurity, and Preparing for Mass Casualty Infectious Diseases Events (Editors: Trish Perl and Daniel Maxwell)

Drs. Cal Albrecht, Emily Dyer, Nicole Kusnik, Shawna Sunagawa and Josh Havens received IDWeek Best Abstract Awards

Jen O’Neill RN received a nursing DAISY Award, nominated by a grateful patient

Dr. Kelly Cawcutt was appointed Vice Chair of the SHEA Spring Mentorship Program Committee

Dr. Josh Havens was honored as a new invention contributor at UNMC

Dr. Jenn Davis was named as one of the top performing reviewers for the journal Clinical Infectious Diseases

Drs. Nico Cortes-Penfield and Angela Hewlett were delegates to the International Consensus Meeting (ICM) in Istanbul with other experts on bone and joint infections from around the world

Dr. Jenn Davis was named as faculty lead on an e-module selected as part of the UNMC E-Learning Awards Program 2025-2026 cohort. Drs. Shawna Sunagawa, Jonathan Ryder, and Nicole Kusnik are also participating

Dr. Angela Hewlett was selected as the Chair of the IDSA Outbreak and Pandemic Preparedness Education Panel

Led by Dr. Anum Abbas and Dr. Carlos A. Gomez, the Transplant Infectious Diseases Research Group had an exceptionally productive year, bringing TEN industry-sponsored, NIH-funded, and investigator-initiated studies to UNMC

The Specialty Care Center Ryan White Part D program was one of 8 programs selected nationally to participate in the HRSA, HAB, & DCHAP “Enhancing HIV Care of Women, Infants, Children and Youth (WICY) Building Capacity through Communities of Practice (CoP)” program focused on Trauma Informed Care and Behavioral Health, utilizing quality improvement interventions (March 2024-March 2025)

Deanna Hansen received recognition for celebrating her 35th anniversary as a UNMC employee

Valentina Orduna was the recipient of the Nebraska Medicine and UNMC Unsung Hero Award

Dr. Mark Rupp served as Interim Chair of the UNMC Department of Internal Medicine

The Specialty Care Center team was 1 of 2 programs selected to present their Community of Practice activities and findings at the DCHAP Stakeholders Webinar in April 2025

Dr. Mark Rupp served on the IDSA taskforce evaluating compensation at academic medical centers

Nikki Regan, APRN was appointed to serve on the Association of Nurses in AIDS Care (ANAC) Rural Care Committee for 2026

Dr. Nada Fadul was appointed HIV Subspeciality Section Co-Chair of the National Medical Association (NMA)

This does not even include the countless publications and presentations by members of this division!

Well done folks, looking forward to the excellence you will bring to 2026!


 

Understanding Health Misinformation: Why It Spreads, Who It Harms, and What We Can Do About It

By Kelly Cawcutt, MD, MS, FACP, FIDSA, FCCM, FSHEA
Medical Director, Acute Care Quality
Senior Medical Director, Infection Prevention & Hospital Epidemiology
(Adapted from Grand Rounds presentation, December 2025; this post is AI supported creation)

Health misinformation isn’t new — but the scale, speed, and impact we’re seeing today is unlike anything in modern history. In 2025, the American Psychological Association released a consensus statement underscoring health misinformation as one of the most urgent threats to public health. The World Health Organization has called this an “infodemic”: an overabundance of information, both accurate and not, that makes it hard for people to find trustworthy guidance when they need it most.

And, much like an infectious pathogen, misinformation spreads quickly, silently, and with significant downstream harm.

In healthcare, understanding misinformation is no longer optional. It’s part of the clinical landscape we navigate every day.


What Counts as Health Misinformation?

Despite its widespread use, the term misinformation has evolved rapidly. Today, it broadly refers to false, misleading, or inaccurate information shared without the intent to deceive. Like a virus, it can be:

  • Hard to detect
  • Rapidly transmissible
  • Emotionally compelling
  • Harmful both to individuals and to public health

Common red flags include sensational claims, emotionally charged or divisive wording, cherry-picked or decontextualized data, and absence of credible sources.


Why Health Misinformation Matters

The consequences go well beyond online confusion:

  • Erosion of trust in clinicians, science, and healthcare systems
  • Delayed or avoided care, including refusal of preventive services
  • Worsening disease severity and outcomes
  • Increased strain on public health infrastructure

As clinicians and health leaders, we often encounter patients whose health beliefs or decisions have been shaped by misinformation long before they see us.


How Misinformation Spreads — and Why People Believe It

Decades of psychological research offer important insights:

1. Repetition Works

People tend to believe information they encounter repeatedly — even if it’s false. This “illusory truth effect” is one of the strongest drivers of misinformation uptake.

2. Emotions Drive Engagement

Fear, anger, surprise, or outrage dramatically increase the likelihood of sharing content online.

3. Misinformation Meets Human Needs

People share information because it aligns with identity, reinforces group belonging, or offers a sense of control and meaning.

4. Anyone Can Be Susceptible

Across demographics and education levels, susceptibility is linked less to intelligence and more to:

  • Cognitive shortcuts
  • Existing belief systems
  • Distrust
  • Information overload

Empathy, not judgment, is essential here.


Addressing Misinformation Begins With Trust

Before any corrective information can land, a foundational question must be answered:

Does your patient or audience trust you?

Mistrust — of institutions, government, or healthcare — is one of the most potent accelerants of misinformation. Building rapport, validating concern, and maintaining transparency are vital.


Evidence-Based Strategies to Address Misinformation

Research from psychology and communication science points to several effective techniques:

1. Pre-bunking (Inoculation Theory)

Like a vaccine, pre-exposure to weakened forms of misinformation — along with explanations of how it misleads — can build resistance.

2. Priming

Setting expectations ahead of time (e.g., “You may hear claims that X — here’s why they’re misleading…”) increases resilience to false information.

3. Debunking

When misinformation must be corrected:

  • Lead with the correct fact first.
  • Explain why the misinformation is incorrect.
  • Replace it with an alternative explanation.
  • Avoid repeating the myth excessively — doing so can inadvertently reinforce it.

4. Practice and Reinforcement

Like any behavioral skill, effective communication requires repetition — for both clinicians and patients. “Boosters” may be needed over time.

5. Beware the Backfire Effect

While rare, corrections can sometimes harden misinformation beliefs. Strategies that emphasize empathy, shared values, and collaborative problem-solving reduce this risk.


A Broader Community Strategy

Healthcare leaders cannot combat misinformation alone. Effective mitigation requires:

  • Collaboration with trusted community leaders and organizations
  • Media and digital literacy training at all ages
  • Policies that support fact-checking, transparency, and responsible platform governance
  • Public health investment in local communication networks
  • Leveraging trusted messengers to reach audiences traditional healthcare may not

The infodemic is a systems-level challenge — and addressing it is a shared responsibility.


Where Social Media Fits In

The role of social media platforms has prompted growing discussion around whether they function as a commercial determinant of health. Algorithms prioritize engagement, not accuracy, creating an environment where emotionally charged misinformation thrives.

And, importantly: you don’t have to, and frankly should not, argue with online posts. Sometimes, the best move is simply not feeding the trolls.


Key Action Points for Clinicians and Leaders

  • Build trust first. No strategy works without it.
  • Use evidence-based communication tools such as pre-bunking, debunking, and replacement.
  • Engage with empathy, not confrontation.
  • Support community-centered partnerships to amplify accurate information.
  • Recognize social media’s influence and the need for institutional responses.
  • Practice ongoing vigilance. The misinformation landscape evolves quickly.

Select References for Further Review

  • Scherer, Laura D., and Gordon Pennycook. “Who is susceptible to online health misinformation?.” American Journal of Public Health 110.S3 (2020): S276-S277.​
  • Chaufan, Claudia, et al. “Trust us—We are the (COVID-19 misinformation) experts: A critical scoping review of expert meanings of “misinformation” in the COVID era.” COVID 4.9 (2024): 1413-1439.​
  • Ecker, Ullrich KH, et al. “The psychological drivers of misinformation belief and its resistance to correction.” Nature Reviews Psychology 1.1 (2022): 13-29.​
  • Denniss, Emily, and Rebecca Lindberg. “Social media and the spread of misinformation: infectious and a threat to public health.” Health promotion international 40.2 (2025): daaf023.​
  • Lalani, Hussain S., et al. “Addressing viral medical rumors and false or misleading information.” Annals of Internal Medicine 176.8 (2023): 1113-1120.​
  • Ho, Kevin KW, and Shaoyu Ye. “Factors affecting the formation of false health information and the role of social media literacy in reducing its effects.” Information 15.2 (2024): 116.​
  • Zhang, Shiyi, Huiyu Zhou, and Yimei Zhu. “Have we found a solution for health misinformation? A ten-year systematic review of health misinformation literature 2013–2022.” International Journal of Medical Informatics 188 (2024): 105478.​
  • Whitehead, Hannah S., et al. “A systematic review of communication interventions for countering vaccine misinformation.” Vaccine 41.5 (2023): 1018-1034.​
  • https://www.apa.org/topics/journalism-facts/misinformation-belief-action
  • Roozenbeek J, van der Linden S. How to Combat Health Misinformation: A Psychological Approach. American Journal of Health Promotion. 2022;36(3):569-575. doi:10.1177/08901171211070958
  • Van der Linden, Sander, et al. “Using psychological science to understand and fight health misinformation: An APA consensus statement.” American Psychologist (2025).​
  • Feng, Xiaoye, et al. “Health Misinformation Detection: Approaches, Challenges and Opportunities.” INQUIRY: The Journal of Health Care Organization, Provision, and Financing 62 (2025): 00469580251384784.


 

UNMC ID Transplant Infectious Diseases Research Group Leads in Division Clinical Trials

Content provided by Drs. Anum Abbas and Carlos Gomez

Under the leadership of Dr. Anum Abbas and Dr. Carlos A. Gomez, the UNMC ID Transplant Infectious Diseases Research Group had an exceptionally productive year, bringing multiple industry-sponsored, NIH-funded, and investigator-initiated studies to UNMC. These efforts expand clinical trial access for immunocompromised patients, strengthen our division’s research mission, and directly contribute to institutional research revenue and academic visibility.

Major Clinical Trials/ Transplant ID /UNMC 2025

High-Enrollment / High-Impact Studies

NIH – COLT Trial (CTOT-44)

  • CMV Vaccine in Orthotopic Liver Transplant Candidates (COLT) – Pivotal NIH-funded randomized trial evaluating CMV vaccination in liver transplant candidates.
    • PI: Sias Scherger | Coordinator: Mary Petersen. → UNMC ranks among the top enrolling sites nationally, and Dr. Scherger was invited to present the UNMC recruitment experience at the 2025 Investigator Meeting—an exceptional recognition for an early-career investigator and a reflection of the strength of our TID research infrastructure.

SymBio Pharmaceuticals – Brincidofovir Program (Adenovirus & CMV)

  • BCV-PA01 (Phase IIa) – Multiple ascending-dose study of IV brincidofovir for adenovirus and CMV infection. 
    • PI: Gomez, Sub-I: Scherger, Abbas | Coordinator: Matthew Palmer. 

AiCuris – Pritelivir Program

  • AIC316-03-II-01 (PRIOH-1) – Randomized trial of pritelivir vs foscarnet for acyclovir-resistant HSV.
    • PI: Abbas, Sub-Is: Gomez, Zimmer | Coordinator: Grace Rodriguez -> (UNMC, Top 5 recruitment site worldwide)

GSK RSV – Adjuvanted RSVPreF3 Vaccine Program

  • RSV OA-ADJ-031 (Phase 2b Extension) – Safety and revaccination durability in adult lung & kidney transplant recipients.
    • PI: Abbas | Coordinator: Caitlin Harrison
      → Strong enrollment positioning UNMC as a national leader in RSV vaccine studies in SOT.

International RSV Consortium (ESCMID ESGREV) – MD Anderson / UNMC

  • RSV Outcomes (2024-0389) – Multicenter registry characterizing RSV in immunocompromised adults.
    • Local Leads: Abbas, Gomez | Coordinator: Matthew Palmer. → Integrates UNMC into a premier international respiratory virus research group.

Additional 2025 Studies Activated at UNMC

Immunocompromised Host Observational & Etiologic Studies

  • IC-SCARI (Strive, NIH network) – Global evaluation of severe acute respiratory infections in immunocompromised adults.
    • PI: Gomez, Abbas | Coordinator: Mary Petersen
  • Karius mGENeSIS Registry – Prospective mNGS registry in solid organ transplant recipients.
    • Local Co-PI: Gomez, Abbas (Baylor, sponsor lead site)
  • Karius IMPACT – Diagnostic mNGS pathway for cardiovascular infections.
    • Co-PI: Gomez, Abbas. (Baylor, sponsor lead site)

Advanced Diagnostic Trials in Transplant & Oncology ID

  • Karius OPTIMUM (KAR-0025) – Randomized basket trial evaluating clinical utility of plasma mcfDNA sequencing in Oncology ID patients.
    • PI: Gomez | Sub-Investigators: Abbas, Scherger, Zimmer, APPs: Knut, Tijerina, Schober| Coordinator: Caitlin Harrison-> first in class diagnostic study in ONC-ID outpatient setting.

Vaccine Trials

  • Pfizer C. difficile Vaccine (C4771002) – Phase III placebo-controlled RCT in adults ≥65.
    • PI: Gomez | Sub-Investigators: Brett Major, Abbas. Coordinator: Neja Menyweather
      → High-visibility national vaccine program added to the TID/ID portfolio.

We are very proud of the Transplant ID Research Group for a very active year with multiple new industry-sponsored, NIH-funded, and international studies launched at UNMC, including several high-enrolling trials and upcoming pivotal projects. These efforts involve a large portion of our research team and reflect our mission to expand clinical trial access and improve care for immunocompromised patients. Our coordinators and collaborating teams put in tremendous work, and we want to recognize these efforts and thank our team for their partnership in our shared goal.


 

rik DOiNsD c

Exciting News: Meet Our Incoming Infectious Diseases Fellows for 2026-2027!

We are thrilled to announce that the Infectious Diseases Fellowship Program at UNMC has successfully filled all positions for the 2026-2027 academic year! Please join us in welcoming our three outstanding fellows who will begin their training in July 2026.

Evangeline Green, D.O.
Medical School:
University of New England College of Osteopathic Medicine
Residency:
University of Nebraska Medical Center
Brianna Desa, D.O.
Medical School: Kansas City University of College of Osteopathic Medicine
Residency: Wayne State University/Detroit Medical Center
Hind Kazkaz, MBBS
Medical School: Alfaisal University College of Medicine
Residency: Creighton University

These talented physicians bring diverse experiences and a shared passion for infectious diseases. We look forward to their contributions to patient care, research, and education during their fellowship.

Stay tuned for more updates as we welcome them to our team!

Blog post created with AI support.


 

iXUXad

Clean Hands, Safe Patients: A National Hand Hygiene Week Message

The first week of December is a time for us to recognize National Hand Hygiene Week. Reflecting on hand hygiene reminds us of the deceptively simple yet profoundly powerful message: clean hands save lives. In healthcare, we face increasingly complex challenges—multidrug-resistant organisms, more invasive procedures, increasing patients with impaired immune systems, all within a fast-paced clinical environment. In the midst of all this complexity, hand hygiene remains a reliable, effective, and accessible tool to prevent healthcare-associated infections (HAIs).

Every infection prevented represents a patient protected, a family spared distress, and a system strengthened. As clinicians and staff, each of us plays a critical role in this effort. Our consistent commitment to hand hygiene is one of the most important contributions we make to patient safety—every single day.

A Quick Refresher: The WHO Five Moments for Hand Hygiene

Hand hygiene is simple, but there are standards to when, and how, to perform it. The WHO Five Moments for Hand Hygiene are the global standard because they work. They anchor hand hygiene to the highest-risk points of pathogen transmission and should be engrained in the minds of all healthcare workers.

The 5 moment for hand hygiene include: before touching a patient, before clean/aseptic procedures, after exposure to body fluid or risk of exposure, after touching a patient and after touching patient surroundings.

These five moments apply across all care settings—from inpatient units to ambulatory clinics, procedural areas, and laboratories. As leaders in Infectious Diseases and Infection Prevention, we must be the example others follow as hand hygiene protects us all, patients and healthcare workers alike.

Why It Still Matters

Hand hygiene is one of the few interventions shown to reduce HAIs across conditions: CLABSI, CAUTI, SSI, C. difficile, and respiratory viral infections. Compliance also serves as a visible expression of our professional standards and shared culture of safety.

Yet even with decades of data, hand hygiene remains an area where slips in consistency often occur and may result in significant consequences. National Hand Hygiene Week is an invitation to reset, recommit, and re-energize our efforts—together.

Quick Resources You Can Share or Bookmark

Thank you for your leadership, attention to detail, and everyday excellence in infection prevention. Your hands truly make a difference.

Post created with AI support.


 

World AIDS Day 2025: Overcoming Disruption, Transforming the AIDS Response

Every year on December 1, the world pauses to reflect, remember, and recommit to ending one of the most significant public health challenges of our time: HIV/AIDS. World AIDS Day, first observed in 1988, is more than a date on the calendar, it’s a global movement to raise awareness, fight stigma, and honor the millions of lives affected by HIV. The iconic red ribbon, adopted in 1991, remains a universal symbol of solidarity and hope.

The official theme for World AIDS Day 2025 is: “Overcoming disruption, transforming the AIDS response.” This theme reflects the urgent need to address setbacks caused by funding cuts, geopolitical instability, and widening inequalities. Despite decades of progress, the global HIV response faces its most significant challenges in years. Health systems are under strain, prevention programs have stalled, and community-led services, especially those supporting women and key populations, are closing due to lack of resources.

Despite decades of progress, HIV continues to disproportionately affect marginalized communities in the U.S. and globally. Black Americans represent 12% of the population but account for 39% of new HIV diagnoses, while Hispanic/Latino individuals make up 19% of the population yet represent 24% of new diagnoses. Among men who have sex with men, lifetime risk is 1 in 3 for Black MSM compared to 1 in 15 for White MSM, underscoring persistent diagnostic gaps. Prevention disparities are equally stark: although PrEP is highly effective, 94% of prescriptions go to White individuals, while only 13% of Black and 24% of Hispanic individuals who could benefit receive it. Even with breakthrough options like long-acting injectables (cabotegravir for PrEP, cabotegravir/rilpivirine and lenacapavir for treatment), uptake remains limited, only 13% of PrEP users in one large health system were on injectable PrEP, and Medicaid coverage often requires prior authorization, creating delays. High costs (e.g., lenacapavir >$40,000 annually) and geographic barriers, particularly in the South where HIV burden is highest, further restrict access. Programs like the Ryan White HIV/AIDS Program, which provides comprehensive care and medication for uninsured and underinsured individuals, remain critical in bridging these gaps. Continued advocacy for equitable access, policy reform, and community engagement is essential to ensure that scientific advances translate into real-world impact for those most affected. 

Rural communities face unique challenges in HIV prevention and treatment. Limited healthcare infrastructure and long travel distances often delay diagnosis and access to antiretroviral therapy. Workforce shortages mean fewer providers trained in HIV care, and awareness of prevention tools like PrEP remains low, one study found that only 1 in 3 rural clinicians were familiar with PrEP. Economic barriers and lack of Medicaid expansion in many states further restrict access to newer options such as long-acting injectables, which can simplify treatment but remain costly and require prior authorization. Stigma and privacy concerns in close-knit communities compound these issues, discouraging individuals from seeking care. Solutions like telehealth, mobile clinics, and Ryan White-funded transportation and support services are helping, but sustained advocacy and investment are essential to ensure rural populations benefit from the same advances driving progress in urban areas. 

The UNMC Specialty Care Clinic plays a critical role in reducing HIV-related health disparities across Nebraska. As a Ryan White Program site, the clinic ensures that uninsured and underinsured individuals receive comprehensive HIV care, including access to antiretroviral therapy, PrEP, and long-acting injectable options. Beyond medical treatment, the clinic addresses social determinants of health through patient navigation services, transportation assistance, and insurance support, helping patients overcome barriers that often lead to delayed diagnosis or treatment interruptions. Its multidisciplinary model integrates primary care, behavioral health, and gender-affirming services, creating a safe and inclusive environment for populations disproportionately affected by HIV. Through community outreach, workforce training, and participation in clinical trials for innovative therapies, the UNMC Specialty Care Clinic is not only delivering cutting-edge care but also advocating for equity, ensuring that scientific advances reach those who need them most. 

Looking ahead, even though ending AIDS as a public health threat by 2030 seems like an insurmountable task, our path to this goal can only be realized if we act boldly. That means investing in prevention, scaling up innovative treatments like long-acting injectables, and protecting human rights for all. This World AIDS Day, let’s unite behind equity, resilience, and community leadership to ensure no one is left behind.

world AIDS day logo with a cream colored pattered background, with black lettering words #WorldAIDSDay2025 and #EndAIDS, and in the right bottom corner is a red triangle, with three people helping each other up

Blog post created with AI support


 

Thanks and Gratitude

This time of year is a time for reflection, gratitude, and appreciation of the blessings we have, and we are grateful for the opportunity to share our thanks from all of us at UNMC ID. 

We want to thank our interim Department Chair Dr. Mark Rupp and Division Chief Dr. David Warren for their ongoing support and encouragement for all of the ID division member activities, including this work on Digital Innovation & Social Media Strategy

We want to thank our faculty, fellows, residents, students and advanced practitioners for their tireless work countless hours taking care of our patients in the hospital and in our clinics

We want to thank our ID pharmacists who have been instrumental in getting key initiatives off the ground, helping us with navigating tough clinical cases, developing our institutional guidelines, and troubleshooting through crises like antibiotic shortages, and continuing our status as an Antimicrobial Stewardship Center for Excellence

We want to thank our Microbiology lab colleagues for their constant partnership and support through routine ID needs, lab updates and renovations, and dealing with crises like blood culture bottle shortages

We want to thank our Public Health partners for their collaboration on efforts to reduce antibiotic resistance across the state and maintain excellence in biopreparedness

We want to thank our ID nurses and clinical staff who have been the glue that keeps our clinics working

We want to thank our clinical colleagues in the hospitals and outpatient settings who trust us daily to consult on their patients and provide extraordinary care

We want to thank our division/clinic administrators and administrative assistants for keeping the nonclinical work on track, and generally keeping us afloat

We want to thank our trainees for allowing us the privilege of teaching them this, and every year

We want to thank our statisticians and research assistants for working so closely with us on research that has brought us again to be the 2nd most productive division in the department of Internal Medicine at UNMC

We want to thank our patients in the hospitals and clinics for the privilege to treat them and in most cases, journey with them to complete resolution of their illnesses.

We want to thank our families and friends who have supported all of us in our health careers

We want to thank all of our blog subscribers, those who forward our blog on to others, support and share our content.

THANK YOU, THANK YOU, THANK YOU, and keep following us for more amazing work in the future!


 

Antibiotic Awareness Week Call To Action: Our Role in Preserving Antibiotics for the Future

Why This Matters

Antibiotics are one of the most powerful tools in modern medicine, but their effectiveness is under threat. Antimicrobial resistance (AMR) is rising globally, and without urgent action, common infections and routine procedures could become life-threatening. Clinicians are uniquely positioned to lead the fight against AMR, not only through prescribing decisions but also through advocacy, education, and system-level change.

Beyond Prescribing: Expanding Your Impact

Stewardship is more than choosing the right antibiotic. It involves shaping a culture of responsible use across healthcare and the community. Here’s how clinicians can make a lasting impact:

  1. Mentor and Educate
    • Teach trainees and colleagues about stewardship principles.
    • Incorporate AMR topics into grand rounds and continuing education sessions.
  2. Advocate for Policy and Resources
    • Support institutional investment in stewardship programs.
    • Engage in local and national advocacy for AMR research funding and access to diagnostics.
  3. Participate in Stewardship Committees
    • Collaborate with pharmacists, infection preventionists, and microbiologists.
    • Help develop protocols for antibiotic time-outs, IV-to-oral switches, and formulary restrictions.
  4. Leverage Data
    • Use prescribing dashboards to monitor trends.
    • Share feedback with peers to improve practice patterns.

Patient Education: A Critical Piece

We can change the narrative and belief that antibiotics are a cure-all treatment for any ailment.

  • Sample Script:

“Antibiotics are powerful medicines, but they only work for bacterial infections. Taking them when they’re not needed can make future infections harder to treat. Let’s focus on what will help you feel better.”

  • Provide clear instructions for symptom relief and when to return for care.
  • Share resources like CDC Antibiotic Use and Symptom Relief Guide.

Check out some scholarly activity from our UNMC ID team on strategies for leading the way in antimicrobial stewardship:

Key Takeaways

  • Stewardship is a professional responsibility that extends beyond prescribing.
  • Clinicians can lead through education, advocacy, and system-level interventions.
  • Every conversation with a patient is an opportunity to promote responsible antibiotic use.

Call to Action:
Join the movement during U.S. Antibiotic Awareness Week. Share your commitment using #USAAW25 and #AntibioticsAware, and explore resources at CDC Antibiotic Awareness Toolkit.


 

Antibiotic Awareness Week: Advancing Health Equity in Antimicrobial Stewardship

Why Equity Matters in Stewardship

Antimicrobial resistance (AMR) is a global health crisis, but its impact is not evenly distributed. Vulnerable populations, especially those with limited access to healthcare, marginalized communities, and patients in resource-limited settings, face disproportionate risks. These disparities stem from systemic barriers, including unequal access to diagnostics, inconsistent prescribing practices, and language or literacy challenges.

Research shows that racial and socioeconomic differences influence antibiotic prescribing patterns, often driven by implicit bias or structural inequities. For example, some groups may receive antibiotics unnecessarily, while others experience delays in appropriate therapy. Both scenarios increase AMR risk and worsen health outcomes.

Clinician Action Steps

  1. Audit Prescribing Patterns for Equity
    Regularly review antibiotic use data by race, ethnicity, and socioeconomic status. Identify trends and address gaps through education and policy changes.
  2. Improve Access to Diagnostics
    Advocate for point-of-care testing in safety-net clinics and rural settings. Accurate diagnosis reduces unnecessary antibiotic use and ensures timely treatment for bacterial infections.
  3. Use Culturally and Linguistically Appropriate Materials
    Provide patient education in multiple languages and formats. The CDC Health Literacy Resources offer tools for creating clear, accessible instructions.
  4. Engage Community Health Workers
    Community-based outreach can bridge gaps in understanding and adherence, especially in populations with limited health literacy.

Why This Matters for Clinicians

Embedding equity into stewardship is not just ethical, it’s essential for effectiveness. When patients lack access to care or clear instructions, antibiotics are misused, resistance spreads, and outcomes worsen. By addressing these gaps, clinicians help ensure stewardship benefits all patients, not just those with resources.

Key Takeaways:

  • AMR disproportionately affects underserved populations.
  • Equity-focused stewardship improves outcomes and reduces resistance.
  • Clinicians can lead by auditing prescribing patterns, improving access, and tailoring education.

Resources